court room with gavel and united states

Zostavax Motion to Dismiss Claim Has Been Denied

Sadaka Associates Defective Drug, Firm News, Mark Sadaka, Vaccine Injury

A federal judge has denied a motion by Merck & Co. Inc. to dismiss a design defect claim against its Zostavax vaccine, finding that the claim was not preempted by federal law under Wyeth v. Levine, 555 U.S. 555 (2009), or its predecessors. Plaintiffs claims that the safer design of Zostavax should not have included a live-attenuated virus and Merck argues …

Mark T. Sadaka quoted by Epoch Times on CDC Lawsuit

Sadaka Associates Firm News, Mark Sadaka

Mark T. Sadaka, founder of Sadaka Associates, a national law firm, was quoted in the Epoch Times regarding a lawsuit against the CDC. The lawsuit was filed by the nonprofit ICAN seeks to have the CDC remove certain claims that vaccines do not cause autism. To read the article and Mr. Sadaka’s comments click Nonprofit to File Lawsuit Against CDC …

hpv attorney meeting

HPV vaccine lawyer Mark Sadaka meets with 11 Japanese Attorneys

Sadaka Associates Defective Drug, Firm News, Mark Sadaka, Vaccine Injury, Vaccine Litigation

Mark Sadaka met with 11 attorneys from Japan who represent 125 women suffering serious injuries resulting from Gardasil. The attorneys sought out Mr. Sadaka for his knowledge and expertise in litigating these cases. Mr. Sadaka is the first and only attorney to successfully prove that the HPV vaccine caused the death of 21-year-old Christina Tarsell. Less than a month after …

Mark T. Sadaka Appointed as Co-lead Counsel in Zostavax National Product Liability Lawsuits

Sadaka Associates Defective Drug, Firm News, Mark Sadaka, Vaccine Litigation

Sadaka Associates founder Mark T. Sadaka was appointed as co-lead counsel of the Zostavax Multi District Litigation (MDL). ENGLEWOOD, N.J. (PRWEB) November 12, 2018 Mark T. Sadaka was appointed by Judge Harvey Bartle of the Eastern District of Pennsylvania as co-lead counsel of the Zostavax Multi District Litigation (MDL). As co-lead counsel, Mr. Sadaka will help lead a team of …

Mark Sadaka argues for Zostavax victims before the Judicial Panel on Multidistrict Litigation

Sadaka Associates Defective Drug, Firm News, Mark Sadaka, Vaccine Litigation

Mark Sadaka travelled to Santa Fe, New Mexico to argue before the Judicial Panel on Multidistrict Litigation for the 1000s of people injured by Zostavax, a vaccine given to adults to prevent shingles. Because there are so many cases, Merck asked for all of the cases to be heard in front of one court. Sadaka Associates argued that the case …

(201) Magazine Discloses the Selection of Mark Sadaka as one of the Top Lawyers in Products Liability in Bergen County, New Jersey.

Sadaka Associates Firm News, Mark Sadaka

This 2016 selection of Mr. Mark Sadaka by a vote of attorneys to be included in (201) magazine’s top lawyers makes it the second time that the accomplished, impressive, talented and experienced lawyer is being selected as one of the prestigious top lawyers in handling of product defective cases in Bergen County, New Jersey. Mark Sadaka established the Law Offices …

What is the Vaccine Injury Compensation Program?

Sadaka Associates Mark Sadaka, Vaccine Litigation

Everyone knows the benefits of receiving vaccinations – but what about the side effects? What happens when they go wrong and you or your child gets sick from receiving a routine vaccination? Vaccine injury claims are not like traditional personal injury claims; they require a lawyer admitted to the vaccine court in Washington, DC. Our vaccine injury lawyers have represented …

Mark Sadaka Selected as one of Bergen County, New Jersey’s Top Lawyers in Products Liability

Sadaka Associates Defective Products, Firm News, Mark Sadaka

Finding a lawyer with experience handling defective products lawsuits in New Jersey can be a challenge. Recent news may make the choice easier. Law Offices of Sadaka Associates is proud to announce that founder Mark Sadaka has been selected by (201) Magazine as one of Bergen County’s Top Lawyers in Products Liability. The firm’s reputation is one of high quality …